Literature DB >> 16030147

Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients.

Andréa Toma1, Samy Haddouk, Jean-Paul Briand, Luc Camoin, Hanne Gahery, Francine Connan, Danielle Dubois-Laforgue, Sophie Caillat-Zucman, Jean-Gérard Guillet, Jean-Claude Carel, Sylviane Muller, Jeannine Choppin, Christian Boitard.   

Abstract

Proinsulin is a key autoantigen in type 1 diabetes. Evidence in the mouse has underscored the importance of the insulin B chain region in autoimmunity to pancreatic beta cells. In man, a majority of proteasome cleavage sites are predicted by proteasome cleavage algorithms within this region. To study CD8+ T cell responses to the insulin B chain and adjacent C peptide, we selected 8- to 11-mer peptides according to proteasome cleavage patterns obtained by digestion of two peptides covering proinsulin residues 28 to 64. We studied their binding to purified HLA class I molecules and their recognition by T cells from diabetic patients. Peripheral blood mononuclear cells from 17 of 19 recent-onset and 12 of 13 long-standing type 1 diabetic patients produced IFN-gamma in response to proinsulin peptides as shown by using an ELISPOT assay. In most patients, the response was against several class I-restricted peptides. Nine peptides were recognized within the proinsulin region covering residues 34 to 61. Four yielded a high frequency of recognition in HLA-A1 and -B8 patients. Three peptides located in the proinsulin region 41-51 were shown to bind several HLA molecules and to be recognized in a high percentage of diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16030147      PMCID: PMC1180789          DOI: 10.1073/pnas.0504230102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library.

Authors:  F S Wong; J Karttunen; C Dumont; L Wen; I Visintin; I M Pilip; N Shastri; E G Pamer; C A Janeway
Journal:  Nat Med       Date:  1999-09       Impact factor: 53.440

Review 2.  Islet cell autoantigens in insulin-dependent diabetes.

Authors:  M A Atkinson; N K Maclaren
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

3.  Development of a fully automated multichannel peptide synthesizer with integrated TFA cleavage capability.

Authors:  J Neimark; J P Briand
Journal:  Pept Res       Date:  1993 Jul-Aug

4.  Cellular immunity to human insulin in individuals at high risk for the development of type I diabetes mellitus.

Authors:  R J Keller
Journal:  J Autoimmun       Date:  1990-06       Impact factor: 7.094

5.  Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases.

Authors:  R K Sibley; D E Sutherland; F Goetz; A F Michael
Journal:  Lab Invest       Date:  1985-08       Impact factor: 5.662

6.  Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus.

Authors:  A Hänninen; S Jalkanen; M Salmi; S Toikkanen; G Nikolakaros; O Simell
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

7.  Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology.

Authors:  B Conrad; E Weidmann; G Trucco; W A Rudert; R Behboo; C Ricordi; H Rodriquez-Rilo; D Finegold; M Trucco
Journal:  Nature       Date:  1994-09-22       Impact factor: 49.962

8.  Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients.

Authors:  N Itoh; T Hanafusa; A Miyazaki; J Miyagawa; K Yamagata; K Yamamoto; M Waguri; A Imagawa; S Tamura; M Inada
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

9.  Pancreas in recent onset insulin-dependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile.

Authors:  N Somoza; F Vargas; C Roura-Mir; M Vives-Pi; M T Fernández-Figueras; A Ariza; R Gomis; R Bragado; M Martí; D Jaraquemada; R Pujol-Borrell
Journal:  J Immunol       Date:  1994-08-01       Impact factor: 5.422

10.  Insulitis in type 1 (insulin-dependent) diabetes mellitus in man--macrophages, lymphocytes, and interferon-gamma containing cells.

Authors:  A K Foulis; M McGill; M A Farquharson
Journal:  J Pathol       Date:  1991-10       Impact factor: 7.996

View more
  45 in total

Review 1.  Viruses and cytotoxic T lymphocytes in type 1 diabetes.

Authors:  Ken T Coppieters; Matthias G von Herrath
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 8.667

2.  Beyond HLA-A*0201: new HLA-transgenic nonobese diabetic mouse models of type 1 diabetes identify the insulin C-peptide as a rich source of CD8+ T cell epitopes.

Authors:  Zoltan Antal; Jason C Baker; Carla Smith; Irene Jarchum; Jeffrey Babad; Gayatri Mukherjee; Yang Yang; John Sidney; Alessandro Sette; Pere Santamaria; Teresa P DiLorenzo
Journal:  J Immunol       Date:  2012-04-25       Impact factor: 5.422

3.  An update on the use of NOD mice to study autoimmune (Type 1) diabetes.

Authors:  Rodolfo José Chaparro; Teresa P Dilorenzo
Journal:  Expert Rev Clin Immunol       Date:  2010-11       Impact factor: 4.473

4.  CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope.

Authors:  Ania Skowera; Richard J Ellis; Ruben Varela-Calviño; Sefina Arif; Guo Cai Huang; Cassie Van-Krinks; Anna Zaremba; Chloe Rackham; Jennifer S Allen; Timothy I M Tree; Min Zhao; Colin M Dayan; Andrew K Sewell; Wendy W Unger; Wendy Unger; Jan W Drijfhout; Ferry Ossendorp; Bart O Roep; Mark Peakman
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

5.  Detection of GAD65 autoreactive T-cells by HLA class I tetramers in type 1 diabetic patients.

Authors:  Laura Giuliani; Raffaella Mele; Monica Di Giovine; Laura Altieri; Antonino Crinò; Lucilla Ravà; Alessandra Fierabracci
Journal:  J Biomed Biotechnol       Date:  2009-12-08

6.  Ins2 deficiency augments spontaneous HLA-A*0201-restricted T cell responses to insulin.

Authors:  Irene Jarchum; Teresa P DiLorenzo
Journal:  J Immunol       Date:  2009-12-04       Impact factor: 5.422

Review 7.  Islet autoantigens: structure, function, localization, and regulation.

Authors:  Peter Arvan; Massimo Pietropaolo; David Ostrov; Christopher J Rhodes
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

8.  Simultaneous detection of circulating autoreactive CD8+ T-cells specific for different islet cell-associated epitopes using combinatorial MHC multimers.

Authors:  Jurjen H Velthuis; Wendy W Unger; Joana R F Abreu; Gaby Duinkerken; Kees Franken; Mark Peakman; Arnold H Bakker; Sine Reker-Hadrup; Bart Keymeulen; Jan Wouter Drijfhout; Ton N Schumacher; Bart O Roep
Journal:  Diabetes       Date:  2010-03-31       Impact factor: 9.461

9.  Deficiency in B7-H1 (PD-L1)/PD-1 coinhibition triggers pancreatic beta-cell destruction by insulin-specific, murine CD8 T-cells.

Authors:  Tarvo Rajasalu; Helen Brosi; Cornelia Schuster; Andreas Spyrantis; Bernhard Otto Boehm; Lieping Chen; Jörg Reimann; Reinhold Schirmbeck
Journal:  Diabetes       Date:  2010-05-18       Impact factor: 9.461

10.  Functional inhibition related to structure of a highly potent insulin-specific CD8 T cell clone using altered peptide ligands.

Authors:  Liliana G Petrich de Marquesini; Antonis K Moustakas; Ian J Thomas; Li Wen; George K Papadopoulos; F Susan Wong
Journal:  Eur J Immunol       Date:  2008-01       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.